In a recent decision, the US District Court of South Carolina reinforces the original intention of patient definition for 340B covered entities, advocating for a ‘broad’ interpretation. Emphasizing the program’s core mission, the ruling reinforces Congress’ initial intent—to safeguard vulnerable communities from skyrocketing drug costs. This reaffirmation solidifies the program’s commitment to ensuring vital access to affordable medications for those most in need, aligning with its original purpose of protecting underserved populations.
Read the court document: U.S. District Court of South Carolina upholds fundamental patient definition for 340B covered entities
